Latest News about OPNT
Recent news which mentions OPNT
   Earnings Scheduled For May 10, 2022
   
  
  
  May 10, 2022
  From Benzinga
 
   70 Biggest Movers From Friday
   
  
  
  May 02, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Friday's Intraday Session
   
  
  
  April 29, 2022
  From Benzinga
 
   48 Stocks Moving In Friday's Mid-Day Session
   
  
  
  April 29, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Earnings Scheduled For March 15, 2022
   
  
  
  March 15, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
   
  
  
  January 25, 2022
  From Benzinga
 
   Under BARDA Contract, Opiant Pharma Secures Additional Funding Of $2M For Opioid Overdose Program
   
  January 25, 2022
  Tickers 
   OPNT
  
  
  From Benzinga
 
   The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective
   
  
  
  January 21, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
   
  
  
  December 09, 2021
  From Benzinga
 
   Earnings Scheduled For November 11, 2021
   
  
  
  November 11, 2021
  From Benzinga
 
   The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
   
  
  
  November 05, 2021
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
   
  
  
  October 06, 2021
  From Benzinga
 
   The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
   
  
  
  October 05, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
   
  
  
  September 22, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
   
  
  
  September 21, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
   
  
  
  September 17, 2021
  From Benzinga
 
   3 Stocks Insiders Are Buying
   
  
  
  September 16, 2021
  From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Monday's After-Market Session
   
  
  
  September 13, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.